NHRA Pharmacist Exam study materials
NHRA Pharmacist Exam study resources

Dispensing a Controlled Substance with a Suspicious Prescription

NHRA Pharmacist Exam · Put your knowledge to work in context.

All case studies

Dispensing a Controlled Substance with a Suspicious Prescription

A community pharmacy receives a prescription for oxycodone 30 mg tablets, quantity 120, signed by a prescriber 40 km away. The patient is a 28-year-old man who is new to the pharmacy and asks to pay cash. The prescription is written on a pad that lacks a printed DEA number, and the signature is a stamp rather than a handwritten signature. The pharmacist calls the prescriber's office; the receptionist confirms the prescriber is out of town and cannot be reached. The patient becomes agitated and says he will report the pharmacy for refusing to fill a valid prescription. State law requires that Schedule II prescriptions be written on a state-issued security form and that the prescriber's DEA number be included.

1. Evaluate the legal and professional issues with this prescription and decide whether to dispense.

Read the worked answer

Legal issues.

  1. Schedule II prescriptions generally require a handwritten or otherwise authorized signature; a stamped signature is not acceptable unless state law specifically permits it. A stamp raises forgery concern.
  2. The prescription lacks the prescriber's DEA number, which is required for controlled substance prescriptions under federal regulations and under the stated state law. Missing DEA number is a red flag.
  3. State law requires a state-issued security form for Schedule II drugs; this pad is not that form. Filling it would violate state law.
  4. Quantity 120 of oxycodone 30 mg is a high quantity for a new patient with no established relationship, and the distance from the prescriber is a geographic red flag.
  5. Cash payment and new-patient status are recognized indicators of possible diversion, though not disqualifying on their own.

Professional and ethical issues. The pharmacist has a corresponding responsibility to ensure the prescription is issued for a legitimate medical purpose in the usual course of professional practice. The pharmacist cannot verify the prescriber because the office says the prescriber is out of town. Filling an unverifiable, non-compliant Schedule II prescription exposes the pharmacist to licensure action and DEA sanctions.

Decision. Do not dispense. The prescription fails multiple legal requirements and cannot be verified. Return the prescription to the patient without confiscating it unless state law requires otherwise, document the refusal and the reasons, and inform the patient of the option to obtain a compliant prescription. Report suspected forgery to the appropriate authority per store policy and state law. Treat the patient respectfully; do not accuse him of forgery. Document the interaction contemporaneously.

2. How should the pharmacist handle the patient's threat to report the pharmacy and communicate the refusal?

Read the worked answer

Communication approach.

  • Stay calm and non-confrontational. Use a private area if possible.
  • Explain clearly that the prescription cannot be filled because it does not meet legal requirements (security form, DEA number, signature) and because the prescriber could not be verified. Frame it as a legal requirement, not a personal accusation.
  • Do not say 'you look like a drug seeker' or imply criminality. Avoid escalating language.
  • Offer concrete next steps: the patient may obtain a compliant prescription on the required security form with a handwritten signature and DEA number, or the prescriber's office may call the pharmacy to verify.
  • Provide the pharmacy manager's contact and the corporate complaint process if the patient wishes to complain.
  • Do not fill the prescription to avoid conflict; doing so would be a legal violation.

Documentation. Record the date, time, prescription details, the reason for refusal, the call to the prescriber's office and the response, the patient's statements, and any staff witnesses. Keep the original prescription if state law requires retention; otherwise return it and note that it was returned.

Follow-up. Inform the pharmacist-in-charge and follow the store's controlled substance refusal policy. If forgery is suspected, report to local law enforcement or the state board as required. Ensure staff are trained on de-escalation and on recognizing altered or forged prescriptions.

3. What red flags in this scenario would a pharmacist document, and how do they relate to corresponding responsibility?

Read the worked answer

Red flags present.

  • Prescription written on a pad without a printed DEA number.
  • Stamped rather than handwritten signature.
  • Not on the state-required security form for Schedule II drugs.
  • High quantity (120 tablets) of a high-strength immediate-release opioid (oxycodone 30 mg).
  • New patient with no established pharmacy relationship.
  • Cash payment.
  • Prescriber located far from the pharmacy, with no apparent relationship to the patient.
  • Prescriber unavailable for verification.

Corresponding responsibility. Federal law places a duty on the pharmacist to ensure that a controlled substance prescription is issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice. The pharmacist shares responsibility with the prescriber. A pharmacist who fills a prescription while ignoring clear red flags can be held liable even if the prescriber wrote it.

Resolution of red flags. The pharmacist should attempt to resolve red flags before dispensing, for example by calling the prescriber, verifying the diagnosis and treatment plan, confirming the patient's identity, and checking the prescription drug monitoring program. In this case, the red flags could not be resolved, and the prescription was legally deficient, so refusal is appropriate. Document which red flags were identified, what steps were taken to resolve them, and the outcome.